Hepatocyte transplantation followed by auxiliary liver transplantation - A novel treatment for ornithine transcarbamylase deficiency

98Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the first successful use of hepatocyte transplantation as a bridge to subsequent auxiliary partial orthotopic liver transplantation (APOLT) in a child antenatally diagnosed with severe ornithine transcarbamylase (OTC) deficiency. A total of 1.74 × 109 fresh and cryopreserved hepatocytes were administered intraportally into the liver over a period of 6 months. Immunosuppression was with tacrolimus and prednisolone. A sustained decrease in ammonia levels and a gradual increase in serum urea were observed except during episodes of sepsis in the first 6 months of life. The patient was able to tolerate a normal protein intake and presented a normal growth and neurological development. APOLT was successfully performed at 7 months of age. We conclude that hepatocyte transplantation can be used in conjunction with APOLT as an effective treatment for severe OTC-deficient patients, improving neurodevelopmental outcomes. © 2008 The Authors.

Cite

CITATION STYLE

APA

Puppi, J., Tan, N., Mitry, R. R., Hughes, R. D., Lehec, S., Mieli-Vergani, G., … Dhawan, A. (2008). Hepatocyte transplantation followed by auxiliary liver transplantation - A novel treatment for ornithine transcarbamylase deficiency. American Journal of Transplantation, 8(2), 452–457. https://doi.org/10.1111/j.1600-6143.2007.02058.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free